T. Rowe Price Group (TROW), Why Is It Getting Attention Now?
T. Rowe Price Group (TROW) has expanded its exchange traded fund lineup with three new fully transparent, actively managed equity products, giving investors additional options in biotechnology, small-cap, and mid-cap strategies.
That ETF expansion arrives at a time when T. Rowe Price Group’s share price has slipped over the past quarter, with a 90 day share price return down 12.23% and a 30 day share price return down 4.52%. At the same time, total shareholder return sits at 7.68% over one year and 18.13% over three years, which points to fading near term momentum but a still positive multi year record.
Scan beyond T. Rowe Price Group’s new ETFs and size up other hand-picked asset managers and diversified financials through the 19 high quality undiscovered gems.
The share price has slipped while analyst targets and intrinsic estimates sit higher, which leaves a wide gap to sort through. Where does fair value for T. Rowe Price Group really land on that spectrum?
Most Popular Narrative: 16.1% Undervalued
On the most followed view, T. Rowe Price Group screens as undervalued, with a fair value of $124 against a last close of $104.05, and that gap depends on how new business lines reshape earnings power over time.
The build out of T. Rowe Price Group’s private credit and broader alternatives platform, including the OHA Select Private Credit Fund expanding to 144 portfolio companies and issuing US$400 million of 6.50% debt due 2031, creates scope for a larger base of management and performance fees that can influence revenue and earnings mix.
See why 3 investors see T. Rowe Price Group as 16% undervalued.
Result: Fair Value of $124 (UNDERVALUED)
Still, T. Rowe Price Group faces ongoing headwinds, with continued net outflows and pressure on effective fee rates that could undercut the bullish fair value story.
Find out about the key risks to this T. Rowe Price Group narrative.
Next Steps
Mixed messages around T. Rowe Price Group can either paralyze you or sharpen your process, so move quickly, review the data, and weigh both sides through the 3 key rewards and 1 important warning sign.
Looking for more investment ideas beyond T. Rowe Price Group?
If you stop with T. Rowe Price Group, you risk missing other opportunities that might fit your style even better, so broaden your research before deciding.
- Target future growth potential by checking companies that screen as high quality and potentially undervalued through the 31 high quality undervalued stocks.
- Prioritize resilience by reviewing a list of solid balance sheet and fundamentals (25 results) that can help shield your portfolio when conditions get tougher.
- Hunt for mispriced potential by scanning a 9 elite penny stocks with strong financials that filters for stronger balance sheets and financial quality.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com